Europe urged to tackle rise in allergiesBMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7095.1641f (Published 07 June 1997) Cite this as: BMJ 1997;314:1641
- Rory Watson
The medical profession, pharmaceutical industry, and public authorities are all being urged to give a higher priority to tackling allergies, which now affect one in three citizens in Europe and whose direct and indirect costs are estimated at Ecu29bn (£22bn; $36bn) annually.
The call for a rethink in present attitudes and policies is contained in a 120 page white paper, Allergic Diseases as a Public Health Problem, produced by the UCB Institute of Allergy, an independent, non-profit making association …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial